Daily Archives: April 30, 2021

Merck announces agreement with India for investigational oral drug molnupiravir with potential implications for over 100 countries

By on .

By Daniel R. Lucey MD, MPH, FIDSA On April 27 Merck issued a press release titled, “Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19.” Merck stated that it “has entered into […]